Veterinary Anti-infectives Market to Grow with a CAGR of 6.45% through 2030
Increasing
focus on food safety and rising investments in animal health infrastructure, is
expected to drive the Global Veterinary Anti-infectives Market growth in the
forecast period, 2026-2030
According to
TechSci Research report, “Veterinary Anti-infectives Market – Global
Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”,
the Global Veterinary Anti-infectives Market stood at USD 8.37 Billion in
2024 and is expected to reach USD 12.20 Billion by 2030 with a CAGR of 6.45% during
the forecast period. The Global Veterinary Anti-infectives Market is expanding
as the role of animal healthcare becomes increasingly vital in sustaining food
systems and supporting the companion animal sector. The growing dependence on
livestock production to meet global protein consumption is amplifying the need
for effective disease management tools. Anti-infectives are central to
preventing economic losses from infectious outbreaks that threaten animal
productivity and trade. Rising pet ownership, coupled with heightened concern
for animal welfare, has also broadened the scope of veterinary medicines beyond
livestock, driving demand for advanced therapies for companion animals. This
rising focus on both food security and pet health has established a strong
foundation for the growth of the veterinary anti-infectives market.
Market growth is
being reinforced by scientific progress and evolving industry practices.
Continuous innovation in veterinary medicine has resulted in the development of
highly specific drugs with improved safety profiles. A strong trend is the
adoption of combination therapies, which provide broader protection and
mitigate resistance development. Growing collaboration between research
institutes and pharmaceutical firms is leading to innovative product pipelines
that align with stricter global standards. Producers and pet owners alike are
becoming more receptive to preventive healthcare approaches, fueling the
adoption of vaccination-linked anti-infective strategies. Another key trend is
the integration of sustainability considerations into animal health practices,
creating demand for eco-friendly formulations that reduce the environmental
impact of veterinary medicines.
Growth
opportunities in the Global Veterinary Anti-infectives Market are significant,
with rising demand for alternatives to traditional antibiotics offering a
promising pathway. Development of natural products such as herbal
anti-infectives, microbiome-modulating therapies, and next-generation biologics
presents vast potential. Increasing investments in digital veterinary platforms
enable real-time health monitoring, opening new avenues for precision dosing
and targeted treatment. Emerging economies represent another key growth
frontier, where rising livestock production and urban pet adoption create
robust demand. Strategic partnerships between pharmaceutical companies,
technology providers, and veterinary networks can accelerate innovation and
market penetration. With expanding emphasis on sustainable farming, consumer
trust in food safety, and continuous scientific advancements, the industry is
well positioned to capture long-term opportunities.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Veterinary Anti-infectives Market”
The Global Veterinary
Anti-infectives Market is segmented into animal type, product, route of
administration, distribution channel, regional distribution, and company.
Based on the Product,
Antivirals emerged as the fastest growing segment in the Global Veterinary
Anti-infectives Market during the forecast period. This is due to the rising prevalence of viral
infections in both livestock and companion animals. Outbreaks of diseases such
as avian influenza, foot-and-mouth disease, feline calicivirus, and canine
parvovirus have created a significant need for effective antiviral therapies to
control transmission and minimize economic losses in animal husbandry. With the
growing global focus on biosecurity and preventive healthcare, demand for
veterinary antivirals has accelerated, particularly in regions with large
livestock populations. These medicines not only reduce mortality rates but also
help ensure food security by protecting the productivity of farm animals. Another
important factor driving the growth of antivirals is the ongoing shift toward
innovative formulations and targeted therapies developed through advanced
research in veterinary virology. Increasing collaborations between
pharmaceutical companies, research institutions, and government agencies have
led to the development of broad-spectrum and species-specific antiviral drugs.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
Veterinary Anti-infectives Market during
the forecast period. This is due to the surge in foreign investments, strategic
collaborations, and R&D initiatives by global veterinary pharmaceutical
companies targeting the region’s unmet needs. Several multinational players are
expanding their production and distribution networks in Asia-Pacific to tap
into the growing demand for affordable and efficient animal healthcare
solutions. The increasing emphasis on antibiotic stewardship, supported by
regulatory reforms in countries such as China and India, is driving the
development of improved formulations and alternatives to traditional
antibiotics. At the same time, the rising trend of pet adoption in urban areas,
coupled with the growing popularity of companion animal healthcare, is fueling
demand for anti-infectives in small animals. With a large livestock population,
improving veterinary awareness, and strong industry investments, Asia-Pacific
is set to emerge as a key growth engine in the global veterinary
anti-infectives market over the coming years.
Major
companies operating in Global Veterinary Anti-infectives Market are:
- Zoetis
Inc.
- Boehringer
Ingelheim Animal Health GmbH
- Merck
& Co., Inc.
- Dechra
Pharmaceuticals PLC
- Elanco
Animal Health Incorporated
- Ceva
Santé Animale S.A.
- Virbac
S.A.
- Biogénesis
Bagó S.A.
- Vetoquinol
S.A.
- Norbrook
Laboratories Limited
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The Global Veterinary Anti-infectives
Market is expanding due to the growing adoption of integrated herd health
management strategies among livestock producers, which focus on combining
preventive vaccination programs, continuous disease surveillance, and targeted
administration of anti-infective therapies. These approaches help in early
detection and control of bacterial, viral, and parasitic infections, reducing
mortality rates and minimizing economic losses associated with outbreaks.
Farmers are increasingly leveraging data-driven insights, veterinary guidance,
and modern farm management practices to optimize animal health, enhance
productivity, and ensure food safety. The trend toward structured herd health
programs is encouraging the use of advanced anti-infectives, creating sustained
demand for innovative veterinary solutions”, said Mr.
Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Veterinary Anti-infectives Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal Type (Livestock Animal, Companion Animal), By Product (Antimicrobial, Antifungals, Antivirals, Antiparasitic, Others), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital/ Clinic Pharmacy, Retail Pharmacies, E-commerce), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global
Veterinary Anti-infectives Market and provides statistics & information on
market size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Veterinary
Anti-infectives Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com